跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRADAXA 150MG CAPSULES - SFDA Drug Approval Details
Approvals
/
SFDA
/
PRADAXA 150MG CAPSULES
Authorized
STANDARD
PRADAXA 150MG CAPSULES
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
06d6610b22dddf54
Company
Unknown
Type
Standard
Approval Details
Approval Id
06d6610b22dddf54
Drug Approval Sfda Name
PRADAXA 150MG CAPSULES
Trade Name
PRADAXA 150MG CAPSULES
Generic Name
DABIGATRAN ETEXILATE
Register Number
0110258289
Route Of Administration
Oral use
Package Type
Blister
Package Size
60
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
do not store above 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000000340-150-100000073375
Price
308
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
06d6610b22dddf54
Type
Standard
Back to SFDA Approvals